Atara Biotherapeutics Inc (ATRA) Insider Trading
- $3,819,989.71
- $54,474,671.30
- Nov. 18, 2024
- Isaac E Ciechanover
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 2, 2019 | Insider | 1,500 | $35.00 | Sell | $52,500.00 | |
Dec. 28, 2018 | CEO | 7,800 | $33.88 | Sell | $264,264.00 | |
Dec. 27, 2018 | CEO | 3,900 | $33.05 | Sell | $128,895.00 | |
Dec. 13, 2018 | CEO | 7,800 | $42.66 | Sell | $332,748.00 | |
Dec. 3, 2018 | Insider | 1,500 | $41.14 | Sell | $61,710.00 | |
Nov. 29, 2018 | CEO | 7,800 | $40.39 | Sell | $315,042.00 | |
Nov. 15, 2018 | EVP | 775 | $33.81 | Sell | $26,202.75 | |
Nov. 14, 2018 | CEO | 3,900 | $33.99 | Sell | $132,561.00 | |
Nov. 7, 2018 | Director | 21,374 | $36.38 | Sell | $777,586.12 | |
Nov. 1, 2018 | Insider | 1,500 | $35.00 | Sell | $52,500.00 | |
Oct. 22, 2018 | CEO | 3,900 | $33.78 | Sell | $131,742.00 | |
Oct. 5, 2018 | CEO | 7,800 | $40.22 | Sell | $313,716.00 | |
Oct. 1, 2018 | Insider | 1,500 | $41.28 | Sell | $61,920.00 | |
Sept. 25, 2018 | EVP | 31,500 | $40.17 | Sell | $1,265,355.00 | |
Sept. 19, 2018 | CEO | 7,800 | $39.81 | Sell | $310,518.00 | |
Sept. 7, 2018 | CEO | 7,800 | $39.35 | Sell | $306,930.00 | |
Sept. 4, 2018 | Insider | 1,500 | $39.45 | Sell | $59,175.00 | |
Aug. 21, 2018 | CEO | 7,800 | $36.37 | Sell | $283,686.00 | |
Aug. 15, 2018 | EVP | 775 | $37.54 | Sell | $29,093.50 | |
Aug. 7, 2018 | CEO | 7,800 | $37.43 | Sell | $291,954.00 | |
Aug. 1, 2018 | Insider | 1,500 | $37.74 | Sell | $56,610.00 | |
July 30, 2018 | Insider | 10,000 | $35.78 | Sell | $357,800.00 | |
July 27, 2018 | CFO | 2,000 | $36.80 | Buy | $73,600.00 | |
July 27, 2018 | CEO | 7,800 | $38.00 | Sell | $296,400.00 | |
July 10, 2018 | CEO | 58,400 | $40.00 | Sell | $2,336,000.00 | |
June 26, 2018 | CEO | 4,400 | $40.31 | Sell | $177,364.00 | |
June 18, 2018 | Director | 2,500 | $44.78 | Sell | $111,950.00 | |
June 6, 2018 | CEO | 8,800 | $48.56 | Sell | $427,328.00 | |
May 22, 2018 | CEO | 8,800 | $51.74 | Sell | $455,312.00 | |
May 18, 2018 | EVP | 25,860 | $50.03 | Sell | $1,293,775.80 | |
May 16, 2018 | Director | 273 | $46.06 | Sell | $12,574.38 | |
May 16, 2018 | EVP | 4,647 | $46.06 | Sell | $214,040.82 | |
May 15, 2018 | SVP | 16,334 | $45.02 | Sell | $735,356.68 | |
May 14, 2018 | Director | 12,286 | $43.57 | Sell | $535,301.02 | |
May 10, 2018 | CEO | 8,800 | $39.85 | Sell | $350,680.00 | |
May 8, 2018 | SVP | 1,544 | $40.15 | Sell | $61,991.60 | |
April 27, 2018 | CEO | 8,800 | $42.46 | Sell | $373,648.00 | |
April 11, 2018 | CEO | 4,400 | $40.82 | Sell | $179,608.00 | |
March 29, 2018 | EVP | 22,400 | $40.07 | Sell | $897,568.00 | |
March 26, 2018 | CEO | 4,400 | $40.10 | Sell | $176,440.00 | |
March 26, 2018 | EVP | 18,327 | $39.79 | Sell | $729,231.33 | |
March 20, 2018 | CFO | 6,000 | $40.41 | Sell | $242,460.00 | |
March 16, 2018 | CEO | 8,800 | $42.13 | Sell | $370,744.00 | |
March 12, 2018 | CEO | 1,000 | $46.31 | Sell | $46,310.00 | |
Feb. 22, 2018 | CEO | 17,800 | $44.65 | Sell | $794,770.00 | |
Feb. 20, 2018 | CEO | 8,700 | $45.28 | Sell | $393,936.00 | |
Feb. 16, 2018 | Director | 1,183 | $46.50 | Sell | $55,009.50 | |
Feb. 16, 2018 | CFO | 13,000 | $47.07 | Sell | $611,910.00 | |
Feb. 16, 2018 | CEO | 20,000 | $46.92 | Sell | $938,400.00 | |
Feb. 14, 2018 | CEO | 20,000 | $46.80 | Sell | $936,000.00 |
Insiders are both buying and selling Atara Biotherapeutics Inc stock.
The insider traders at Atara Biotherapeutics Inc are: Isaac E Ciechanover, Joe Newell, Christopher Haqq, Carol Giltner Gallagher, John Mcgrath, Pascal Touchon, Utpal Koppikar, Gad Soffer, Amar Murugan, Jakob Dupont, Eric J Hyllengren, Mitchall G Clark, Anhco Nguyen, Derrell Porter, Joel S Marcus, Eric Dobmeier, Kristin Yarema, Matthew K Fust, Mitchall G. Clark, Jill Henrich, Heather D Turner, William K Heiden, Domain Partners Viii, L.P., and Isaac E. Ciechanover
The most active insider trader at Atara Biotherapeutics Inc is Isaac E Ciechanover with 102 trades.
Isaac E Ciechanover has sold the most Atara Biotherapeutics Inc stock with a total value of $26,010,505.70.
Domain Partners Viii, L.P. has bought the most Atara Biotherapeutics Inc stock with a total value of $5,459,498.00.
The most recent insider trade for Atara Biotherapeutics Inc was on Nov. 18, 2024.
The single biggest insider buy for Atara Biotherapeutics Inc was from Domain Partners Viii, L.P. with a total value of $2,729,749.00 on Oct. 21, 2014.
The single biggest insider sell for Atara Biotherapeutics Inc was from Isaac E Ciechanover with a total value of $2,336,000.00 on July 10, 2018.